The ability to assess the distribution and extent of tau pathology in Alzheimer’s disease and
progressive supranuclear palsy in vivo would help to develop biomarkers for these …

Alzheimer’s disease and progressive supranuclear palsy (PSP) represent neurodegenerative
tauopathies with predominantly cortical versus subcortical disease burden. In Alzheimer’s …

Neuroinflammation is a key part of the etio-pathogenesis of Alzheimer's disease (AD). We
tested the relationship between neuroinflammation and the disruption of functional …

Tau pathology, neuroinflammation, and neurodegeneration are key aspects of Alzheimer’s
disease. Understanding whether these features predict cognitive decline, alone or in …

Inflammation is increasingly recognized as part of the pathology of neurodegenerative
conditions such as Alzheimer’s disease and Parkinson’s disease, but its role in dementia with …

The clinical syndromes of frontotemporal dementia are clinically and neuropathologically
heterogeneous, but processes such as neuroinflammation may be common across the disease …

Objective We tested whether in vivo neuroinflammation relates to the distinctive distributions
of pathology in Alzheimer disease (AD) and progressive supranuclear palsy (PSP). …

Frontotemporal dementia is clinically and neuropathologically heterogeneous, but
neuroinflammation, atrophy and cognitive impairment occur in all of its principal syndromes. Across …

… general linear models with t-tests for each region of interest, excluding extraparenchymal
regions, first comparing each patient to the control group, as a case series (cf Bevan Jones et …

Serotonin is implicated in multiple executive functions including goal-directed learning, cognitive
flexibility, response inhibition and emotional regulation. These functions are impaired in …